Pleasanton, CA, United States of America

Elzbieta Wiktoria Puchacz


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elzbieta Wiktoria Puchacz: Innovator in Recombinant Protein Technologies

Introduction

Elzbieta Wiktoria Puchacz is a notable inventor based in Pleasanton, CA, who has made significant contributions to the field of biotechnology. With a focus on recombinant proteins, she has developed innovative methods that enhance the production of therapeutic antibodies. Her work is particularly relevant in the context of treatments for various diseases, including those targeting tumor necrosis factor alpha.

Latest Patents

Elzbieta holds two patents that showcase her expertise in protein engineering. The first patent details methods for making recombinant proteins, specifically antibodies, with a focus on anti-tumor necrosis factor alpha antibodies, such as adalimumab. This invention also includes methods and compositions for mammalian cell culture, particularly utilizing Chinese Hamster Ovary cells. The second patent mirrors the first, emphasizing the same innovative approaches to protein production and cell culture techniques.

Career Highlights

Throughout her career, Elzbieta has worked with prominent organizations, including Coherus Biosciences, Inc. Her experience in these companies has allowed her to refine her skills in biotechnology and contribute to advancements in therapeutic solutions.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Elzbieta Wiktoria Puchacz is a pioneering inventor whose work in recombinant protein technologies has the potential to impact the field of medicine significantly. Her patents reflect her dedication to advancing therapeutic methods, making her a valuable contributor to biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…